Betty Tong

1.9k total citations
16 papers, 1.1k citations indexed

About

Betty Tong is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Betty Tong has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Betty Tong's work include Lung Cancer Treatments and Mutations (4 papers), RNA modifications and cancer (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Betty Tong is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), RNA modifications and cancer (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Betty Tong collaborates with scholars based in United States and Italy. Betty Tong's co-authors include Adrian Barbul, Philip N. Tsichlis, H. Leighton Grimes, Joseph A. Califano, David Sidransky, Tung O. Chan, Patrick A. Zweidler‐McKay, William H. Westra, Patrick K. Ha and Jay S. Markowitz and has published in prestigious journals such as Journal of Clinical Investigation, Molecular and Cellular Biology and International Journal of Cancer.

In The Last Decade

Betty Tong

15 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Betty Tong United States	11	417	252	243	130	118	16	1.1k
Lynn E. Macdonald United States	18	676 1.6×	188 0.7×	196 0.8×	511 3.9×	53 0.4×	43	1.7k
Yanhui Fan China	13	446 1.1×	195 0.8×	175 0.7×	87 0.7×	37 0.3×	38	908
Somboon Keelawat Thailand	17	222 0.5×	207 0.8×	72 0.3×	36 0.3×	103 0.9×	68	832
Yu Si China	21	385 0.9×	183 0.7×	87 0.4×	334 2.6×	124 1.1×	81	1.1k
Song Ren Canada	18	186 0.4×	41 0.2×	100 0.4×	133 1.0×	49 0.4×	35	753
Takashi Sakamoto Japan	19	347 0.8×	287 1.1×	53 0.2×	207 1.6×	63 0.5×	52	1.8k
Dan Cui China	18	442 1.1×	151 0.6×	87 0.4×	99 0.8×	9 0.1×	67	1.0k
Amy L. Olex United States	16	398 1.0×	223 0.9×	56 0.2×	90 0.7×	43 0.4×	55	1.0k
Gregory Tudor United Kingdom	19	526 1.3×	328 1.3×	164 0.7×	59 0.5×	34 0.3×	28	1.3k

Countries citing papers authored by Betty Tong

Since Specialization

Citations

This map shows the geographic impact of Betty Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Betty Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Betty Tong more than expected).

Fields of papers citing papers by Betty Tong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Betty Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Betty Tong. The network helps show where Betty Tong may publish in the future.

Co-authorship network of co-authors of Betty Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Betty Tong. A scholar is included among the top collaborators of Betty Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Betty Tong. Betty Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Wood, C. G., Jacob M. Kaufman, Jeffrey Crawford, et al.. (2025). Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis. Journal for ImmunoTherapy of Cancer. 13(2). e010395–e010395. 1 indexed citations

Harowicz, Michael R., et al.. (2025). The Duke Lung Cancer Screening (DLCS) Dataset: A Reference Dataset of Annotated Low-Dose Screening Thoracic CT. Radiology Artificial Intelligence. 7(4). e240248–e240248.

Tong, Betty, et al.. (2022). Predictors of Early Onset Glaucoma. Clinical ophthalmology. Volume 16. 1925–1932. 2 indexed citations

Schnell, Ulrike, Christopher Chaney, Betty Tong, et al.. (2021). Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma. Journal of Clinical Investigation. 131(11). 14 indexed citations

Groot, Patricia M. de, Jonathan H. Chung, Jeanne B. Ackman, et al.. (2019). ACR Appropriateness Criteria® Noninvasive Clinical Staging of Primary Lung Cancer. Journal of the American College of Radiology. 16(5). S184–S195. 31 indexed citations

Hong, Julian C., Matthew J. Boyer, Daphna Y. Spiegel, et al.. (2019). Increasing PET Use in Small Cell Lung Cancer: Survival Improvement and Stage Migration in the VA Central Cancer Registry. Journal of the National Comprehensive Cancer Network. 17(2). 127–139. 9 indexed citations

Tong, Betty & David H. Harpole. (2011). Molecular Markers for Incidence, Prognosis, and Response to Therapy. Surgical Oncology Clinics of North America. 21(1). 161–175. 5 indexed citations

Tong, Betty, Malcolm V. Brock, T. R. E. Pilkington, et al.. (2004). Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer. International Journal of Cancer. 113(6). 1022–1025. 34 indexed citations

Tong, Betty & Adrian Barbul. (2004). Cellular and Physiological Effects of Arginine. Mini-Reviews in Medicinal Chemistry. 4(8). 823–832. 142 indexed citations

10.

Xing, Mingzhao, Henning Usadel, Yoram Cohen, et al.. (2003). Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing.. PubMed. 63(9). 2316–21. 125 indexed citations

11.

Tong, Betty, Patrick K. Ha, Mingzhao Xing, et al.. (2003). Mitochondrial DNA alterations in thyroid cancer. Journal of Surgical Oncology. 82(3). 170–173. 33 indexed citations

12.

Geetha, Duvuru, Betty Tong, Lorraine C. Racusen, Jay S. Markowitz, & William H. Westra. (2002). Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation. 73(12). 1933–1936. 110 indexed citations

13.

Ha, Patrick K., Sara I. Pai, William H. Westra, et al.. (2002). Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity.. PubMed. 8(5). 1203–9. 116 indexed citations

14.

Ha, Patrick K., Betty Tong, William H. Westra, et al.. (2002). Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation.. PubMed. 8(7). 2260–5. 94 indexed citations

15.

Tong, Betty, H. Leighton Grimes, Tong‐Yuan Yang, et al.. (1998). The Gfi-1B Proto-Oncoprotein Represses p21^WAF1 and Inhibits Myeloid Cell Differentiation. Molecular and Cellular Biology. 18(5). 2462–2473. 104 indexed citations

16.

Grimes, H. Leighton, Tung O. Chan, Patrick A. Zweidler‐McKay, Betty Tong, & Philip N. Tsichlis. (1996). The Gfi-1 Proto-Oncoprotein Contains a Novel Transcriptional Repressor Domain, SNAG, and Inhibits G ₁ Arrest Induced by Interleukin-2 Withdrawal. Molecular and Cellular Biology. 16(11). 6263–6272. 236 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact